Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.54 USD | -0.94% | -0.27% | -2.39% |
05-24 | Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi | MT |
05-24 | Novavax awaits FDA decision on whether its next COVID shot can be offered in US | RE |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SANOFI | Other Pharmaceuticals | -0.94% | -0.27% | -2.39% | -7.70% | +14.81% | 121B | - | - | - |
- Stock Market
- Equities
- SAN Stock
- SNY Stock
- Charts Sanofi
- Relative Strength Chart